Archive Sample Retrieval + Biospecimen Collection + pH Low Insertion Peptide-exatecan Conjugate CBX-12 + Radiologic Imaging Procedure for sarcoma, ewing

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Sep 2026: Trial registered, NCT07830667

The trials

NCT07830667: A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat

State
Not started
Phase
Phase 1 and Phase 2
People
79 planned
Started
7 May 2027
Primary completion
30 Jun 2033
Arms
Treatment (CBX-12)
Results
None posted
  1. 21 Sep 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.